{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:05:11Z","timestamp":1791497111243,"version":"4.3.4"},"reference-count":30,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunology Research"],"published-print":{"date-parts":[[2022,2,25]]},"abstract":"<jats:p>C-Type lectin receptor 5A (CLEC5A) is a spleen tyrosine kinase- (Syk-) coupled pattern recognition receptor expressed on myeloid cells and involved in the innate immune response to viral and bacterial infections. Activation of the CLEC5A receptor with pathogen-derived antigens leads to a secretion of proinflammatory mediators such as TNF-\u03b1 and IL-6 that may provoke a systemic cytokine storm, and CLEC5A gene polymorphisms are associated with the severity of DV infection. In addition, the CLEC5A receptor was mentioned in the context of noninfectious disorders like chronic obstructive pulmonary disease (COPD) or arthritis. Altogether, CLEC5A may be considered as an innate immune checkpoint capable to amplify proinflammatory signals, and this way contributes to infection or to aseptic inflammation. In this study, we determined CLEC5A receptor expression on different macrophage subsets (in vitro and ex vivo) and the functional consequences of its activation in aseptic conditions. The CLEC5A surface expression appeared the highest on proinflammatory M1 macrophages while intermediate on tumor-associated phenotypes (M2c or TAM). In contrast, the CLEC5A expression on ex vivo-derived alveolar macrophages from healthy donors or macrophages from ovarian cancer patients was hardly detectable. Targeting CLEC5A on noninflammatory macrophages with an agonistic \u03b1-CLEC5A antibody triggered a release of proinflammatory cytokines, resembling a response to dengue virus, and led to phenotypic changes in myeloid cells that may suggest their reprogramming towards a proinflammatory phenotype, e.g., upregulation of CD80 and downregulation of CD163. Interestingly, the CLEC5A agonist upregulated immune-regulatory molecules like CD206, PD-L1, and cytokines like IL-10, macrophage-derived chemokine (MDC\/CCL22), and thymus and activation chemokine (TARC\/CCL17) which are associated with an anti-inflammatory or a protumorigenic macrophage phenotype. In the absence of concomitant pathogenic or endogenous danger signals, the CLEC5A receptor activation did not amplify an autologous T cell response, which may represent a protective innate mechanism to avoid an undesirable autoimmune adaptive response.<\/jats:p>","DOI":"10.1155\/2022\/9926305","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T15:21:49Z","timestamp":1645802509000},"page":"1-22","source":"Crossref","is-referenced-by-count":22,"title":["Activation of the Innate Immune Checkpoint CLEC5A on Myeloid Cells in the Absence of Danger Signals Modulates Macrophages\u2019 Function but Does Not Trigger the Adaptive T Cell Immune Response"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4117-750X","authenticated-orcid":true,"given":"Milena J.","family":"Tosiek","sequence":"first","affiliation":[{"name":"Cancer Immunology & Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8127-0050","authenticated-orcid":true,"given":"Kerstin","family":"Groesser","sequence":"additional","affiliation":[{"name":"Cancer Immunology & Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-4740","authenticated-orcid":true,"given":"Anton","family":"Pekcec","sequence":"additional","affiliation":[{"name":"Research Beyond Borders, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2006-6061","authenticated-orcid":true,"given":"Monika","family":"Zwirek","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC), Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-4929","authenticated-orcid":true,"given":"Gavuthami","family":"Murugesan","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC), Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-3983","authenticated-orcid":true,"given":"Eric","family":"Borges","sequence":"additional","affiliation":[{"name":"Cancer Immunology & Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-1580-4_3"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3HI1114-531R"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57682"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090516"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.10.016"},{"key":"6","doi-asserted-by":"crossref","first-page":"32000","DOI":"10.1038\/srep32000","article-title":"Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-\u03b1 production by mononuclear phagocytes","volume":"6","author":"Y. L. Cheng","year":"2016","journal-title":"Scientific reports"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1038\/nature07013"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002655"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01813-16"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00356-3"},{"key":"11","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/s41467-019-10360-4","article-title":"Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A\/TLR2","volume":"10","author":"P.-S. Sung","year":"2019","journal-title":"Nature Communications"},{"key":"12","volume-title":"MDL-1 Ligand","author":"W. D. C. Joyce-Shaikh","year":"2015"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0508329"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500978"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0622-0"},{"key":"16","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"J. A. Doudna","year":"2014","journal-title":"Science"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.05.002"},{"key":"18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.lfs.2019.03.062","article-title":"Attributes of alternatively activated (M2) macrophages","volume":"224","author":"R. Shrivastava","year":"2019","journal-title":"Life Sciences"},{"key":"19","first-page":"491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"G. A. Duque","year":"2014","journal-title":"Frontiers in Immunology"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27646"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-430090"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601667"},{"key":"23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.imbio.2008.07.008","article-title":"From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection","volume":"213","author":"O. Sharif","year":"2008","journal-title":"Immunobiology"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166474"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086105"},{"key":"26","article-title":"Elevated expression of C-type lectin domain family 5-member A (CLEC5A) and its relation to inflammatory parameters and disease course in adult-onset still\u2019s disease","volume":"2020","author":"P. K. Chen","year":"2020","journal-title":"Journal of Immunology Research"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-019-0140-8"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.10.122"},{"key":"29","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1089\/cmb.2019.0235","article-title":"Screening of critical genes involved in metastasis and prognosis of high-grade serous ovarian cancer by gene expression profile data","volume":"27","author":"R. Wang","year":"2020","journal-title":"Journal of Computational Biology"},{"key":"30","article-title":"Identification of an immune-related prognostic gene CLEC5A based on immune microenvironment and risk modeling of ovarian cancer","volume":"9, article 746932","author":"J. Shen","year":"2021","journal-title":"Frontiers in Cell and Development Biology"}],"container-title":["Journal of Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/jir\/2022\/9926305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jir\/2022\/9926305.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jir\/2022\/9926305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T15:21:59Z","timestamp":1645802519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/jir\/2022\/9926305\/"}},"subtitle":[],"editor":[{"given":"Enrique","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":30,"alternative-id":["9926305","9926305"],"URL":"https:\/\/doi.org\/10.1155\/2022\/9926305","relation":{},"ISSN":["2314-7156","2314-8861"],"issn-type":[{"value":"2314-7156","type":"electronic"},{"value":"2314-8861","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,25]]}}}